Learning Objectives

It is expected that the 2019 ESC Guidelines on Dyslipidaemias will change the prevention landscape being more aggressive in LDL reduction for high-risk groups. It is important to focus and educate cardiologists on this very important prevention chapter

Key opinion leaders will discuss:

• Grey zones of prevention. Which patients show enhanced risk?
• How low is very low concerning LDL?
• When to add ezetimibe?
• When to add PCSK9?
• This webinar shall educate and provide the cardiologist with all the up-to-date knowledge on the 2019 ESC Guidelines on Dyslipidaemias.

After this webinar physicians should be able to:

• Identify patient populations for the new targets;
• Learn the rationale behind these targets; and
• Feel more confident about hypolipidemic drugs safety.

This webinar addresses general cardiologists but also cardiologists wishing to update their scientific knowledge on the topic.